(CLB) Core Laboratories - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384
CLB: Reservoir, Description, Enhancement, Services, Products, Oil, Gas
Core Laboratories N.V., listed on the New York Stock Exchange (NYSE) under the ticker symbol CLB, is a global leader in providing specialized services and products to the oil and gas industry. Headquartered in Houston, Texas, the company has been a cornerstone of innovation since its founding in 1936. Core Laboratories operates through two primary business segments: Reservoir Description and Production Enhancement, each tailored to address critical challenges in hydrocarbon exploration and extraction.
The Reservoir Description segment focuses on the detailed analysis of petroleum reservoir rock and fluid samples. This involves advanced laboratory testing and field-based services to characterize the properties of crude oil and other petroleum products. The segment also offers proprietary studies and specialized services that support emerging areas such as carbon capture, utilization, and storage (CCUS), geothermal energy projects, and the evaluation of mining activities. These services are designed to enhance oil and gas production while improving recovery efficiency from clients reservoirs.
The Production Enhancement segment delivers a comprehensive suite of services and products aimed at optimizing well completions, perforations, and stimulation operations. This includes integrated diagnostic solutions to evaluate and monitor the effectiveness of well completions, as well as tailored solutions to improve the efficiency of enhanced oil recovery (EOR) projects. By leveraging cutting-edge technology and data-driven insights, Core Laboratories helps its clients maximize production outputs and extend the lifecycle of their wells.
Core Laboratories employs a multifaceted approach to market its offerings, combining the efforts of sales representatives, technical experts, and industry events. The company also utilizes trade shows, print media, and a network of distributors to ensure its products and services reach a global audience. This strategic mix of direct engagement and indirect distribution channels underscores the companys commitment to maintaining its leadership position in the oil and gas equipment and services sector.
Looking ahead, Core Laboratories is well-positioned to navigate the evolving energy landscape. As the oil and gas industry grapples with the dual challenges of energy transition and operational efficiency, the companys expertise in reservoir optimization and production optimization will likely remain in demand. With a market capitalization of $789.97 million and a forward P/E ratio of 17.95, Core Laboratories appears to be attractively valued for investors seeking exposure to the sector. Its price-to-book ratio of 3.14 and return on equity of 12.18% further highlight its financial resilience and profitability. As Aswath Damodaran might note,
Additional Sources for CLB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLB Stock Overview
Market Cap in USD | 695m |
Sector | Energy |
Industry | Oil & Gas Equipment & Services |
GiC Sub-Industry | Oil & Gas Equipment & Services |
IPO / Inception | 1995-09-20 |
CLB Stock Ratings
Growth 5y | 11.5% |
Fundamental | 44.6% |
Dividend | 18.6% |
Rel. Strength Industry | -8.08 |
Analysts | 2.67/5 |
Fair Price Momentum | 12.64 USD |
Fair Price DCF | 21.36 USD |
CLB Dividends
Dividend Yield 12m | 0.24% |
Yield on Cost 5y | 0.50% |
Annual Growth 5y | -32.24% |
Payout Consistency | 86.4% |
CLB Growth Ratios
Growth Correlation 3m | -70.9% |
Growth Correlation 12m | 5.9% |
Growth Correlation 5y | -36% |
CAGR 5y | 12.70% |
CAGR/Max DD 5y | 0.18 |
Sharpe Ratio 12m | -0.10 |
Alpha | -17.47 |
Beta | 1.21 |
Volatility | 48.74% |
Current Volume | 316.3k |
Average Volume 20d | 346.7k |
As of March 14, 2025, the stock is trading at USD 14.70 with a total of 316,254 shares traded.
Over the past week, the price has changed by +4.33%, over one month by -15.47%, over three months by -24.34% and over the past year by -8.38%.
Partly, yes. Based on ValueRay Fundamental Analyses, Core Laboratories (NYSE:CLB) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.63 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of March 2025 is 12.64. This means that CLB is currently overvalued and has a potential downside of -14.01%.
Core Laboratories has received a consensus analysts rating of 2.67. Therefor, it is recommend to hold CLB.
- Strong Buy: 0
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, CLB Core Laboratories will be worth about 14.2 in March 2026. The stock is currently trading at 14.70. This means that the stock has a potential downside of -3.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 18.7 | 27% |
Analysts Target Price | 19.3 | 31.5% |
ValueRay Target Price | 14.2 | -3.5% |